The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R?

Br J Haematol. 2018 Dec;183(5):815-819. doi: 10.1111/bjh.15036. Epub 2017 Nov 28.

Bing Li^{1

2}, Jinqin Liu², Zefeng Xu^{1

2}, Tiejun Qin¹, Zhongxun Shi¹, Zhen Song³, Huijun Huang¹, Liwei Fang¹, Hongli Zhang¹, Lijuan Pan¹, Naibo Hu¹, Shiqiang Qu¹, Yue Zhang^{1

2}, Gang Huang⁴, Zhijian Xiao^{1

2}

¹ MDS and MPN Centre, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
² State Key Laboratory of Experimental Haematology, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
³ Medical Service Division, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
⁴ Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

No abstract available

Keywords: gene mutation; myelodysplastic syndrome; prognostic model.

Publication types